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ABSTRACT	  
	   A	  novel	  non-­‐natural	  amino	  acid	  designed	  to	  bind	  divalent	  metal	  ions,	  dubbed	  Lys(PYRIT),	  
was	  prepared	  in	  a	  “click	  reaction”	  by	  treating	  Fmoc-­‐Lys(N3)-­‐OH	  with	  2-­‐ethynylpyridine	  and	  
Cu(I).	  It	  was	  incorporated	  into	  a	  12-­‐residue	  peptide	  using	  standard	  Fmoc	  solid	  phase	  synthesis	  
protocols.	  	  Multiple	  spectroscopic	  techniques	  (NMR,	  ESI-­‐QToF-­‐MS,	  UV-­‐vis,	  and	  CD)	  confirm	  that	  
the	  PYRIdinyl/Triazolyl	  side-­‐chain	  binds	  Zn(II)	  and	  Cu(II)	  in	  the	  presence	  of	  competing	  natural	  
residues	  such	  as	  histidine	  and	  glutamic	  acid.	  	  It	  remains	  unclear	  whether	  metal	  ions	  mediate	  
the	  oligomerization	  of	  the	  Y2K	  PYRIT	  peptide,	  as	  is	  believed	  to	  be	  important	  in	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INTRODUCTION	  
1.1 Alzheimer’s	  Disease	  and	  the	  Significance	  of	  Neurodegenerative	  Disorders	  
Alzheimer’s	  disease	  (AD)	  is	  an	  irreversible	  neurodegenerative	  disorder	  that	  is	  the	  
leading	  cause	  of	  dementia	  in	  those	  over	  the	  age	  of	  65.	  	  This	  disease	  is	  characterized	  by	  the	  
inability	  to	  perform	  simple	  tasks	  along	  with	  loss	  of	  cognitive	  functioning,	  memory,	  and	  
reasoning.	  	  It	  also	  has	  a	  multiple	  negative	  effects	  on	  the	  behavior	  of	  those	  afflicted	  by	  the	  
disorder.	  	  Currently	  it	  is	  estimated	  that	  between	  2.4	  and	  4.5	  million	  Americans	  suffer	  from	  AD,	  
depending	  on	  the	  method	  of	  measurement.1,2	  	  There	  are	  no	  known	  cures.	  However,	  recent	  
studies	  have	  shown	  a	  slowing	  of	  progression	  in	  the	  presence	  of	  metal	  chelators,	  implicating	  
transition	  metal	  ions	  like	  Cu(II)	  in	  the	  disease.	  	  
There	  are	  two	  types	  of	  AD,	  early-­‐	  and	  late-­‐onset.	  	  Early-­‐onset	  Alzheimer’s	  disease	  is	  
much	  more	  rare	  and	  affects	  people	  between	  the	  ages	  of	  30	  and	  60.	  Most	  cases	  of	  early-­‐onset	  
Alzheimer’s	  are	  inherited,	  and	  are	  therefore	  known	  as	  familial	  AD	  (FAD).2	  Late-­‐onset	  
Alzheimer’s	  disease	  is	  the	  more	  prevalent	  form	  that	  primarily	  affects	  those	  over	  the	  age	  of	  65.	  
The	  cause	  of	  Alzheimer’s	  disease	  is	  not	  entirely	  clear	  but	  there	  have	  been	  arguments	  
supporting	  genetic	  as	  well	  as	  environmental	  contributing	  factors.2	  	  
The	  genetic	  cause	  of	  Alzheimer’s	  has	  been	  narrowed	  to	  a	  region	  of	  chromosome	  19	  
where	  the	  gene	  coding	  for	  apolipoprotein	  E	  can	  be	  found.	  	  There	  are	  three	  alleles	  of	  the	  APOE	  
protein	  including	  ε2,	  ε3,	  and	  ε4.2	  Those	  with	  the	  APOE	  ε2	  allele	  are	  less	  likely	  to	  contract	  AD,	  or	  
contract	  it	  later	  in	  life.	  	  The	  APOE	  ε3	  allele	  has	  been	  shown	  to	  be	  neutral	  towards	  AD,	  while	  the	  
APOE	  ε4	  gene	  occurs	  in	  40%	  of	  those	  with	  AD.	  This	  gene	  doesn’t	  necessarily	  cause	  AD	  but	  there	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is	  strong	  correlation	  between	  the	  APOE	  ε4	  allele	  and	  an	  increased	  risk	  of	  developing	  
Alzheimer’s	  disease.2	  
Although	  the	  cause	  remains	  unclear,	  the	  pathway	  for	  the	  formation	  of	  characteristic	  
amyloid-­‐beta	  plaques	  has	  been	  elucidated.	  	  Amyloid-­‐beta	  (Aβ)	  plays	  a	  critical	  role	  in	  the	  
mechanism	  of	  neurodegeneration	  and	  contributes	  to	  the	  development	  of	  AD	  through	  oxidative	  
stress,	  mitochondrial	  dysfunction,	  impaired	  synaptic	  transmission,	  the	  disruption	  of	  membrane	  
integrity,	  and	  impaired	  axonal	  transport.3	  It	  has	  been	  found	  that	  the	  transmembrane	  amyloid	  
precursor	  protein	  (APP)	  can	  undergo	  one	  of	  two	  processes	  during	  cleavage.	  	  Figure	  1.1	  below	  
shows	  the	  normal	  structure	  of	  APP	  and	  the	  cleavage	  enzymes	  embedded	  in	  the	  neuronal	  
membrane.	  
	  
Figure	  1.1:	  Structure	  of	  Amyloid	  Precursor	  Protein	  (APP)	  and	  cleavage	  enzymes	  in	  the	  
neuronal	  membrane.2	  
In	  the	  normal	  benign	  pathway,	  the	  transmembrane	  protein	  APP	  is	  cleaved	  by	  alpha-­‐
secretase	  within	  the	  portion	  that	  would	  become	  the	  amyloid-­‐beta	  protein.	  	  The	  cleaved	  portion	  
of	  APP,	  sAPPα,	  has	  been	  found	  to	  promote	  neuronal	  growth	  and	  development.2	  The	  remaining	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portion	  of	  APP	  is	  then	  cleaved	  a	  second	  time	  by	  gamma-­‐secretase,	  releasing	  the	  remaining	  
amyloid-­‐beta	  portion	  outside	  of	  the	  cell	  and	  leaving	  the	  larger	  portion	  of	  APP	  inside	  the	  cell	  to	  
interact	  with	  the	  nucleus	  to	  support	  growth	  (Figure	  1.2).	  
	   	  
Figure	  1.2:	  Benign	  cleavage	  pathway	  of	  Amyloid	  Precursor	  Protein.2	  
In	  the	  harmful	  APP	  cleavage	  pathway,	  beta-­‐secretase	  cleaves	  the	  APP	  molecule	  at	  one	  
end	  of	  the	  amyloid-­‐beta	  peptide	  releasing	  sAPPβ	  to	  the	  outside	  of	  the	  neuron.	  	  Gamma-­‐
secretase	  then	  cleaves	  the	  remaining	  APP	  molecule	  in	  its	  normal	  location	  at	  the	  other	  end	  of	  
the	  amyloid-­‐beta	  peptide.2	  This	  sequence	  of	  cleavages	  releases	  intact	  amyloid-­‐beta	  peptide	  
from	  the	  neuronal	  membrane	  to	  the	  cell’s	  exterior	  (Figure	  1.3).	  
	  
Figure	  1.3:	  Harmful	  cleavage	  pathway	  of	  Amyloid	  Precursor	  Protein.2	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The	  amyloid-­‐beta	  (Aβ)	  peptides	  that	  are	  released	  from	  the	  neuronal	  membrane	  in	  the	  
harmful	  cleavage	  pathway	  then	  begin	  to	  form	  oligomers,	  which	  are	  groups	  of	  two	  or	  more	  
peptides	  aggregated	  together.	  	  	  These	  oligomers	  are	  thought	  to	  interact	  with	  specific	  synaptic	  
connections	  between	  neurons,	  affecting	  neuronal	  communication.2	  As	  more	  Aβ	  peptides	  group	  
together,	  the	  oligomers	  form	  protofibrils	  and	  fibrils.	  	  The	  fibrils	  eventually	  group	  together	  with	  
other	  cellular	  material	  and	  proteins	  to	  form	  insoluble	  plaques	  that	  are	  characteristic	  of	  AD.2	  A	  
number	  of	  other	  neurodegenerative	  disorders,	  such	  as	  Parkinson’s	  disease	  and	  Huntington’s	  
disease,	  are	  also	  caused	  by	  protein	  misfolding	  and	  aggregation.3,	  4	  	  	  
	  	  	   	  
Figure	  1.4:	  (a)	  Plaque	  formation	  by	  amyloid-­‐beta	  peptide.2	  (b)	  Plaque	  disruption	  of	  neuronal	  
communication	  and	  signaling.2	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1.2 Protein	  Aggregation	  and	  Metal	  Binding	  
After	  amyloid-­‐beta	  protein	  is	  released	  from	  the	  neuronal	  membrane	  it	  begins	  to	  form	  
oligomers,	  which	  eventually	  lead	  to	  the	  development	  of	  insoluble	  plaques.	  	  Current	  research	  
suggests	  that	  amyloid-­‐beta	  binds	  metal	  cations	  such	  as	  Zn(II)	  or	  Cu(II)	  to	  facilitate	  
oligomerization.	  Copper	  ions	  bind	  to	  soluble	  Aβ	  and	  precipitate	  them	  in	  slightly	  acidic	  solution	  
(pH	  6.6),	  while	  zinc	  ions	  bind	  to	  soluble	  Aβ	  and	  precipitate	  them	  over	  a	  wider	  range	  of	  pH	  (pH	  
5.5-­‐7.5).3	  	  Histidine	  residues	  within	  the	  amyloid-­‐beta	  peptide	  play	  a	  critical	  role	  in	  metal	  
binding.	  	  The	  nitrogen	  contained	  within	  the	  imidazole	  functional	  group	  donates	  a	  pair	  of	  
electrons	  to	  the	  metal	  cations,	  acting	  as	  a	  monodentate	  ligand.	  A	  histidine	  residue	  at	  position	  
13	  binds	  Zn(II)	  in	  human	  Aβ1-­‐40	  but	  is	  substituted	  for	  arginine	  in	  rat	  Aβ1-­‐40.	  	  This	  histidine	  residue	  
is	  crucial	  for	  the	  aggregation	  of	  Aβ-­‐-­‐aggregation	  is	  reduced	  in	  rat	  peptides	  when	  compared	  to	  
those	  of	  humans.4,	  5	  	  	  Histidine	  residues	  6,	  13,	  and	  14	  in	  the	  amyloid-­‐beta	  peptide	  are	  
responsible	  for	  binding	  Zn(II).	  In	  general,	  histidine	  is	  the	  amino	  acid	  most	  commonly	  involved	  in	  
metal	  binding	  among	  the	  naturally	  occurring	  amino	  acids,	  but	  other	  residues	  such	  as	  glutamate,	  
aspartate,	  and	  tryptophan	  may	  play	  a	  role	  in	  metal	  binding.	  Based	  on	  computational	  modeling,	  
it	  has	  been	  found	  that	  histidine	  has	  a	  stronger	  binding	  affinity	  for	  Cu2+	  than	  glutamate,	  
aspartate,	  or	  tryptophan.6	  Histidine	  was	  found	  to	  have	  a	  ΔGbinding	  =	  374.9	  kcal/mol	  while	  
glutamate	  was	  found	  to	  have	  a	  ΔG	  =	  298.0	  with	  absolute	  values	  provided.6	  
Current	  research	  is	  being	  performed	  with	  Cu/Zn	  chelators	  to	  see	  if	  they	  can	  inhibit	  
peptide	  aggregation.	  The	  drug	  Clioquinol,	  for	  example,	  has	  been	  shown	  to	  slow	  the	  progression	  
of	  AD	  by	  dissolving	  plaques	  and	  preventing	  new	  oligomers	  from	  forming.7	  	  Chelators	  operate	  by	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essentially	  sequestering	  the	  metal	  ions,	  preventing	  them	  from	  binding	  amyloid-­‐beta.	  	  One	  
strong	  chelator	  that	  has	  been	  studied	  is	  the	  bidentate	  biheterocycle	  2,2-­‐bipyridine	  (bipy).	  	  The	  
structure	  of	  bipy	  is	  shown	  below	  in	  Figure	  1.5.	  
NN
Zn 	  
Figure	  1.5:	  2,2-­‐Bipyridine	  chelating	  a	  Zn(II)	  metal	  cation.	  
Recent	  research	  has	  been	  directed	  toward	  adding	  bipy-­‐like	  functional	  groups	  to	  the	  side	  
chains	  of	  natural	  amino	  acids.8,9,10	  	  Bipy	  fills	  two	  coordination	  sites	  on	  a	  metal	  ion,	  one	  from	  
each	  nitrogen	  lone	  pair,10	  allowing	  for	  strong	  peptide-­‐metal	  binding	  with	  fewer	  residues	  than	  
normally	  required	  to	  bind	  a	  metal	  cation.	  The	  bipy	  functional	  group	  has	  been	  incorporated	  onto	  
alanine	  residues	  and	  has	  been	  shown	  to	  bind	  Zn2+	  more	  efficiently	  than	  natural	  amino	  acids.10	  A	  
recent	  study	  by	  the	  Schultz	  group	  designed	  a	  genetically	  encoded	  bipyradylalanine	  amino	  acid.9	  
Another	  study	  synthesized	  a	  1,2,3-­‐triazole	  on	  the	  side	  chain	  of	  alanine	  to	  resemble	  the	  
structure	  of	  histidine.8	  	  	  By	  synthesizing	  new	  protected	  amino	  acids	  with	  a	  stronger	  affinity	  for	  
metal	  ions,	  researchers	  have	  fuller	  control	  over	  the	  sites	  and	  stoichiometry	  of	  metal	  binding	  
within	  a	  given	  peptide.	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1.3 Amino	  Acid	  Azide-­‐Alkyne	  Click	  Chemistry	  
“Click	  chemistry”	  is	  a	  term	  that	  was	  coined	  by	  Sharpless	  to	  describe	  reactions	  that	  have	  
very	  high	  yields,	  no	  byproducts,	  and	  that	  almost	  invariably	  work.11	  The	  original	  and	  best-­‐known	  
click	  reaction,	  the	  Huisgen	  1,3-­‐dipolar	  cycloaddition	  between	  a	  terminal	  alkyne	  and	  an	  organic	  
azide,	  can	  produce	  an	  undesired	  mixture	  of	  two	  triazole	  regioisomers	  (1,4	  and	  1,5).	  	  The	  groups	  
of	  Meldal	  and	  later	  Sharpless	  showed	  that	  by	  using	  a	  copper(I)	  catalyst,	  only	  the	  1,4	  















Figure	  1.6:	  1,3	  dipolar	  cycloaddition	  of	  alkyne	  and	  azide	  producing	  only	  1,4	  regioisomer.	  
A	  few	  sources	  have	  reported	  performing	  click-­‐chemistry	  reactions	  on	  Fmoc-­‐protected	  
amino	  azides.9,11,12	  	  Some	  researchers	  have	  modified	  amino	  acids	  containing	  alcohols	  to	  
become	  amino	  azides	  through	  Mitsunobu	  reactions.13	  Most	  other	  peptidotriazoles	  prepared	  to	  
date	  have	  incorporated	  the	  heterocycles	  within	  the	  peptide	  backbone	  or	  on	  one	  terminus	  of	  
the	  peptide	  or	  the	  other.	  The	  following	  chapter	  will	  detail	  our	  efforts	  to	  incorporate	  pyridyl-­‐
triazoles	  into	  amino	  acid	  side	  chains.	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CHAPTER	  2:	  SYNTHESIS	  OF	  FMOC-­‐LYS(PYRIT)-­‐OH	  AND	  Y2K	  PYRIT	  
2.1	  Synthesis	  of	  Fmoc-­‐Lys(PYRIT)-­‐OH	  via	  Azide-­‐Alkyne	  Click	  Chemistry	  
The	  Crowley	  group	  at	  the	  University	  of	  Otago	  synthesized	  2-­‐pyridyl-­‐1,2,3-­‐triazole	  
compounds	  via	  “click”	  chemistry	  and	  determined	  that	  they	  bind	  to	  metals	  very	  well.14	  We	  
reasoned	  that	  this	  reaction	  should	  yield	  1,2,3-­‐triazoles	  on	  the	  side	  chains	  of	  azide-­‐bearing	  
amino	  acid	  residues,	  allowing	  for	  incorporation	  of	  robust	  metal	  binding	  properties	  into	  
peptides.	  Based	  on	  the	  high	  affinities	  for	  metals	  of	  2,2-­‐bipyridine	  and	  2-­‐pyridyl-­‐1,2,3-­‐triazole	  
systems,	  the	  latter	  (Figure	  2.1)	  should	  bind	  metal	  cations	  such	  as	  Cu(II)	  and	  Zn(II),	  provided	  they	  
can	  “outcompete”	  naturally-­‐occurring	  residues	  like	  His	  and	  Glu.	  The	  “PYRIT”	  name	  was	  chosen	  
to	  highlight	  the	  presence	  of	  PYRIdine	  and	  Triazole	  units,	  while	  emphasizing	  that	  this	  work	  was	  







Figure	  2.1:	  Structure	  of	  pyridinyl-­‐triazolyl	  functional	  group	  binding	  to	  a	  Zn(II)	  metal	  cation.	  
To	  develop	  a	  general	  platform	  for	  installing	  metal	  binding	  functionality	  into	  any	  peptide,	  
we	  decided	  to	  modify	  lysine	  residues.	  	  Lysine	  naturally	  contains	  a	  primary	  amino	  group	  that	  can	  
be	  easily	  converted	  to	  an	  azide	  through	  use	  of	  an	  azide	  transfer	  agent	  like	  TMS-­‐N3.15,16	  To	  our	  
knowledge,	  no	  one	  has	  previously	  added	  a	  pyridinyl-­‐triazolyl	  group	  to	  Lys.	  	  An	  azide	  could	  be	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added	  to	  other	  natural	  amino	  acids,	  but	  initial	  addition	  of	  a	  primary	  amine	  to	  the	  terminus	  of	  
the	  side-­‐chain	  would	  require	  additional	  steps.	  	  	  Scheme	  2.1	  shows	  our	  approach	  to	  the	  addition	  
of	  a	  pyridyl-­‐triazolyl	  group	  to	  the	  side	  chain	  of	  lysine	  in	  two	  steps:	  an	  azide	  transfer	  reaction	  
followed	  by	  a	  Huisgen	  1,3-­‐cycloaddition	  that	  forms	  a	  triazole.15,16,17	  	  
	  
Scheme	  2.1:	  Synthesis	  of	  Fmoc-­‐Lys(PYRIT)-­‐OH	  from	  FMOC-­‐Lys-­‐OH	  
	   Imidazole-­‐1-­‐sulfonyl	  azide	  hydrochloride	  was	  first	  prepared	  on	  a	  3	  gram	  scale	  in	  
quantitative	  yield	  (Scheme	  2.1).15	  This	  azide	  transfer	  unit	  can	  be	  purchased	  but	  is	  easily	  
synthesized	  in	  lab.	  Fmoc-­‐Lys(N3)-­‐OH,	  while	  commercially	  available,	  is	  prohibitively	  expensive.	  It	  
was	  therefore	  prepared	  using	  commercially	  available	  Fmoc-­‐Lys-­‐OH.16	  	  The	  azide	  transfer	  
reaction	  was	  performed	  in	  distilled	  water,	  methanol,	  and	  dichloromethane	  in	  a	  3:6:4	  (v:v:v)	  
ratio.	  The	  reaction	  was	  catalyzed	  by	  copper(II)	  sulfate	  pentahydrate,	  and	  potassium	  carbonate	  
was	  used	  to	  obtain	  a	  pH	  of	  9,	  effectively	  deprotonating	  the	  primary	  amine.	  The	  reaction	  was	  
performed	  under	  an	  inert	  atmosphere	  of	  nitrogen	  gas,	  and	  afforded	  a	  98%	  yield	  of	  the	  Fmoc-­‐
Lys(N3)-­‐OH	  after	  24	  h	  of	  reaction	  time.	  The	  lysine-­‐azide	  species	  was	  then	  incorporated	  into	  a	  
Huisgen	  1,3-­‐cycloaddition	  reaction	  to	  generate	  Fmoc-­‐Lys(PYRIT)-­‐OH.17	  	  This	  reaction	  was	  
catalyzed	  by	  copper(I)	  iodide,	  in	  the	  presence	  of	  1.5	  equivalents	  of	  2-­‐ethynylpyridine,	  yielding	  
approximately	  15%	  of	  the	  desired	  product.	  Once	  the	  reaction	  was	  completed,	  the	  Fmoc-­‐
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Lys(PYRIT)-­‐OH	  was	  purified	  through	  reversed-­‐phase	  HPLC	  as	  a	  brown,	  sticky,	  resin-­‐like	  
compound.	  	  After	  lyophilization,	  tens	  of	  milligrams	  of	  the	  pure,	  dried	  amino	  acid	  could	  be	  
obtained	  at	  a	  time	  as	  a	  brick-­‐red	  solid.	  
	  
2.2	  Spectroscopic	  Properties	  of	  Fmoc-­‐Lys(PYRIT)-­‐OH	  
	   After	  synthesizing	  the	  novel	  amino	  acid	  Fmoc-­‐Lys(PYRIT)-­‐OH,	  HPLC	  on	  a	  C18	  column	  was	  
used	  for	  purification.	  	  Using	  gradient	  elution	  from	  75%	  CH3CN/25%	  H20	  to	  25%	  CH3CN	  /75%	  
H20,	  the	  desired	  compound	  eluted	  at	  approximately	  22	  minutes.	  This	  separation	  was	  performed	  
on	  a	  Vydac	  Protein	  and	  Peptide	  C18	  prep	  scale	  column	  (22	  x	  250	  mm,	  20	  μm)	  with	  a	  flow	  rate	  of	  
10.00	  mL/min	  and	  detector	  set	  to	  300	  nm.	  The	  suspected	  peak	  was	  collected	  and	  mass	  
spectrometry	  was	  used	  to	  determine	  the	  identity	  (Figure	  2.2).	  The	  purified	  Fmoc-­‐Lys(PYRIT)-­‐OH	  
was	  then	  subjected	  to	  HPLC	  again	  to	  confirm	  its	  purity,	  yielding	  one	  peak	  at	  22	  minutes	  (Figures	  
2.3	  and	  2.4).	  	  The	  UV-­‐vis	  detector	  was	  set	  to	  detect	  at	  214,	  280,	  and	  300	  nm	  during	  these	  trials.	  	  
Peptide	  bonds	  and	  many	  other	  biological	  molecules	  are	  detectable	  at	  214	  nm	  while	  tryptophan	  
and	  tyrosine	  residues	  are	  detectable	  at	  280	  nm.	  The	  PYRIT	  functional	  group	  has	  strongest	  
electronic	  absorption	  at	  300	  nm.	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Figure	  2.2:	  Mass	  spectra	  (ESI-­‐QToF)	  of	  purified	  Fmoc-­‐Lys(PYRIT)-­‐OH	  ([M+H]+	  =	  498.2136).	  
	   	  
	  
Figure	  2.3:	  HPLC	  chromatogram	  of	  pure	  Fmoc-­‐Lys(PYRIT)-­‐OH	  detected	  at	  300	  nm.	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Figure	  2.4:	  HPLC	  chromatogram	  of	  pure	  Fmoc-­‐Lys(PYRIT)-­‐OH	  detected	  at	  214,	  280,	  and	  300	  
nm.	  
	  
2.3	  Solid	  Phase	  Synthesis	  of	  Y2K	  PYRIT	  Peptide	  
	   With	  approximately	  55	  mg	  of	  the	  purified	  Fmoc-­‐Lys(PYRIT)-­‐OH	  in	  hand,	  we	  wished	  to	  
confirm	  if	  it	  could	  be	  used	  in	  standard	  automated	  peptide	  synthesis.	  It	  was	  thus	  incorporated	  
into	  a	  12-­‐residue	  peptide,	  the	  sequence	  of	  which	  was	  derived	  from	  a	  recent	  publication	  from	  
the	  DeGrado	  group.18	  	  These	  researchers	  from	  the	  University	  of	  California	  at	  San	  Francisco	  
developed	  an	  alpha-­‐helical	  peptide	  called	  “Rocker”	  which	  was	  shown	  to	  form	  tetramers	  within	  
a	  lipid	  bilayer;	  the	  tetrameric	  assembly	  is	  capable	  of	  transporting	  zinc	  ions	  across	  the	  
membrane.	  	  The	  12-­‐residue	  sequence	  containing	  the	  zinc-­‐binding	  site	  was	  taken	  from	  the	  N-­‐
terminus	  of	  24-­‐residue	  “Rocker:”	  	  	  
Rocker:	  YYKEIAHALFSALFALSELYIAVRY	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A	  majority	  of	  the	  residues	  in	  Rocker	  are	  hydrophobic,	  as	  it	  was	  designed	  to	  localize	  in	  
membranes.	  To	  ensure	  water-­‐solubility	  of	  our	  12-­‐mer	  for	  various	  studies,	  the	  second	  Tyr	  
residue	  was	  substituted	  with	  Lys,	  to	  give	  control	  peptide	  “Y2K:”	  
Y2K:	  YKKEIAHALFSA-­‐CONH2	  
Finally,	  Lys(PYRIT)	  was	  installed	  at	  the	  second	  lysine	  (position	  3	  in	  the	  sequence)	  	  The	  
Lys(PYRIT)	  was	  inserted	  here	  because	  it	  was	  expected	  to	  be	  close	  enough	  to	  the	  His	  at	  position	  
7	  to	  allow	  for	  a	  metal	  ion	  to	  form	  a	  bridge	  bewteen	  both	  residues.	  	  (The	  Rocker	  peptide	  binds	  
zinc	  between	  the	  Glu	  at	  residue	  4	  and	  the	  His	  at	  residue	  7.)	  
Y2K(PYRIT):	  YK(PYRIT)EIAHALFSA-­‐CONH2	  
	   The	  12-­‐residue	  Y2K	  and	  Y2K(PYRIT)	  were	  synthesized	  using	  standard	  solid	  phase	  
synthesis	  protocols	  and	  then	  cleaved	  off	  of	  the	  resin.	  Its	  identity	  was	  confirmed	  by	  ESI-­‐MS	  
(Figure	  2.6).	  
	  
Figure	  2.5:	  Structure	  of	  Y2K	  PYRIT	  peptide	  shown	  with	  Lys(PYRIT)	  at	  residue	  3.	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Figure	  2.6:	  Mass	  spectrum	  of	  Y2K	  PYRIT	  showing	  [M+H]+	  =	  1505.8012	  and	  [M+2H]2+	  =	  
753.4042.	  
	  
2.4	  On	  Resin	  Synthesis	  of	  FMOC-­‐LYS(PYRIT)-­‐OH	  	  
	   An	  on-­‐resin	  synthesis	  of	  a	  peptide	  12-­‐mer	  containing	  a	  Lys(PYRIT)	  residue	  was	  
attempted,	  to	  determine	  whether	  the	  “click	  reaction”	  could	  be	  performed	  by	  the	  automated	  
synthesizer.	  At	  the	  outset,	  it	  was	  unknown	  whether	  the	  triazole-­‐forming	  reaction	  would	  
tolerate	  DMF	  solvent	  and	  the	  presence	  of	  other	  functional	  groups	  from	  the	  resin	  and	  peptide	  
strand.	  The	  reaction	  vessel	  of	  the	  peptide	  synthesizer	  was	  first	  loaded	  with	  Rink	  Amide	  resin	  
and	  copper(I)	  iodide.	  	  Fmoc-­‐Lys(azide)-­‐OH	  was	  loaded	  into	  a	  vial	  at	  the	  desired	  Lys(PYRIT)	  
position.	  	  The	  next	  vial	  in	  the	  sequence	  contained	  2-­‐ethynyl	  pyridine	  and	  sodium	  ascorbate.	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After	  the	  Lys(azide)	  was	  incorporated	  into	  the	  peptide,	  the	  2-­‐ethynylpyridine	  and	  sodium	  
ascorbate	  were	  dissolved	  with	  DMF	  in	  the	  usual	  manner,	  and	  upon	  automated	  transfer	  to	  the	  
reaction	  vessel,	  a	  color	  change	  suggested	  a	  reaction	  was	  occurring.	  The	  crude	  peptide	  so	  
obtained	  was	  purified	  via	  HPLC	  to	  yield	  YYKEIAHALK(PYRIT)SA,	  which	  was	  confirmed	  through	  
ESI-­‐MS	  with	  an	  m/z	  of	  1521.7961.	  	  Synthesis	  of	  the	  Fmoc-­‐Lys(azide)-­‐OH	  is	  not	  required	  as	  it	  is	  
commercially	  available.	  By	  performing	  the	  “click”	  reaction	  on	  resin,	  the	  synthesis	  and	  
incorporation	  of	  Lys(PYRIT)	  is	  widely	  available	  to	  biochemists	  and	  other	  no-­‐	  organic	  chemists	  if	  
a	  protein	  synthesizer	  is	  available.	  	  	  
	  
Figure	  2.7	  Mass	  spectrum	  of	  YYKEIAHALK(PYRIT)SA	  showing	  [M+H]+	  =	  1521.7961	  and	  
[M+2H]2+	  =	  761.4017.	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CHAPTER	  3:	  Y2K	  PYRIT	  METAL	  BINDING	  STUDIES	  
3.1	  Computational	  Studies	  
	   Computational	  studies	  were	  performed	  to	  determine	  whether	  the	  PYRIT	  functional	  
group	  would	  bind	  zinc	  and	  copper	  ions,	  and	  more	  specifically,	  if	  two	  PYRIT	  functional	  groups,	  on	  
the	  same	  peptide,	  could	  coordinate	  a	  single	  copper(II)	  in	  a	  square	  planar	  geometry.	  	  According	  
to	  DFT	  analyses,	  if	  the	  two	  PYRIT	  functional	  groups	  approach	  the	  metal	  cation	  in	  a	  head	  to	  head	  
fashion	  (Figure	  3.1),	  the	  binding	  would	  not	  be	  stable	  due	  to	  steric	  hindrance.	  In	  contrast,	  if	  the	  
two	  PYRIT	  groups	  bound	  the	  metal	  cation	  in	  a	  head-­‐to-­‐tail	  fashion,	  the	  dihedral	  angle	  is	  
lowered	  and	  the	  binding	  is	  possible.	  	  This	  led	  to	  the	  conclusion	  that	  if	  two	  PYRIT	  groups	  were	  to	  
bind	  one	  metal	  ion,	  the	  two	  residues	  would	  have	  to	  be	  far	  enough	  apart	  in	  the	  peptide	  to	  form	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(a)	   	   	   	   	   	   	   (b)	  
Figure	  3.1:	  Side	  by	  side	  comparison	  showing	  (a)	  head	  to	  tail	  orientation	  (29.9°	  dihedral	  angle)	  
and	  (b)	  head	  to	  head	  orientation	  (43.7°	  dihedral	  angle)	  of	  two	  PYRIT	  functional	  groups	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   Further	  computational	  analysis	  was	  performed	  after	  the	  12-­‐mer	  was	  identified	  as	  the	  
targeted	  peptide.	  	  A	  five-­‐residue	  sequence	  from	  the	  Y2K	  PYRIT	  peptide	  was	  selected	  for	  
modeling.	  	  This	  sequence	  began	  with	  PYRIT	  at	  the	  N-­‐terminus	  and	  went	  to	  Histidine	  at	  the	  C-­‐
terminus,	  therefore	  the	  sequence	  was	  K(PYRIT)EIAH.	  	  It	  was	  first	  modeled	  in	  a	  solvent	  
continuum	  corresponding	  to	  water	  to	  determine	  if	  the	  suspected	  alpha	  helical	  secondary	  
structure	  would	  be	  favored.	  The	  structure	  was	  determined	  to	  be	  stable	  in	  an	  alpha	  helical	  
structure	  and	  more	  studies	  are	  being	  conducted	  to	  determine	  if	  the	  helix	  is	  conserved	  after	  
metal	  binding	  between	  the	  PYRIT	  residue	  and	  the	  His	  residue.	  	  
	  
Figure	  3.2:	  DFT-­‐optimized	  structure	  of	  helical	  K(PYRIT)EIAH	  in	  a	  solvent	  continuum	  
corresponding	  to	  water.	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3.2	  Nuclear	  Magnetic	  Resonance	  Studies	  
	   Proton	  NMR	  studies	  were	  performed	  in	  D2O	  to	  determine	  which	  of	  the	  residues	  in	  Y2K	  
PYRIT	  were	  binding	  to	  the	  metal	  cations.	  	  These	  studies	  were	  conducted	  by	  titrating	  in	  Zn(II).	  	  
Copper	  was	  unable	  to	  be	  tested	  using	  NMR	  because	  of	  its	  paramagnetic	  properties.	  	  A	  proton	  
NMR	  spectrum	  was	  first	  acquired	  for	  the	  pure	  Y2K	  peptide	  to	  determine	  the	  chemical	  shifts	  of	  
the	  PYRIT	  peaks.	  Figure	  3.3	  shows	  the	  aromatic	  region	  of	  the	  Y2K	  control	  peptide	  while	  Figure	  
3.4	  shows	  the	  aromatic	  region	  of	  Y2K	  PYRIT.	  
	  
	  
Figure	  3.3:	  Aromatic	  region	  of	  the	  1H-­‐NMR	  spectrum	  of	  Y2K	  control	  in	  D2O.	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Figure	  3.4:	  Aromatic	  region	  of	  the	  1H-­‐NMR	  spectrum	  of	  Y2K(PYRIT)	  during	  titration	  with	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After	  inspection	  of	  the	  proton	  NMR	  spectra	  of	  Y2K	  and	  Y2K	  PYRIT,	  it	  was	  determined	  
that	  the	  peaks	  corresponding	  to	  the	  PYRIT	  unit	  appear	  at	  the	  following	  chemical	  shift	  values:	  
7.42,	  7.87,	  7.93,	  8.35,	  and	  8.46	  ppm.	  	  These	  peaks	  are	  present	  in	  the	  Y2K	  PYRIT	  spectrum	  but	  
are	  not	  present	  for	  control	  Y2K.	  	  Each	  of	  these	  peaks	  shifts	  downfield	  as	  more	  zinc	  is	  titrated	  
into	  the	  Y2K	  PYRIT	  solution.	  	  After	  20.0	  eq	  of	  Zn(II)	  has	  been	  added,	  the	  aromatic	  protons	  
exhibit	  chemical	  shift	  values	  of	  7.65,	  7.95,	  8.17,	  8.58,	  and	  8.62	  ppm,	  respectively.	  This	  is	  
consistent	  with	  the	  zinc	  ion	  binding	  the	  PYRIT	  functional	  group,	  deshielding	  the	  surrounding	  
protons.	  
	  
3.3	  Mass	  Spectrometry	  Studies	  
	   The	  Y2K	  PYRIT	  peptide	  was	  further	  analyzed	  using	  mass	  spectrometry	  while	  titrating	  in	  
Zn(II)	  in	  the	  form	  of	  Zn(BF4)2.	  	  As	  shown	  in	  Figure	  3.5,	  both	  free	  Y2K	  PYRIT	  and	  zinc-­‐bound	  Y2K	  
PYRIT	  were	  initially	  present	  before	  adding	  any	  zinc.	  	  This	  suggests	  that	  PYRIT	  is	  such	  an	  effective	  
metal	  binder	  that	  it	  was	  able	  to	  bind	  adventitious	  metal	  ions	  found	  in	  the	  glassware,	  solvent,	  or	  
within	  the	  mass	  spectrometry	  instrument.	  	  As	  more	  Zn(II)	  was	  introduced,	  the	  Y2K	  PYRIT-­‐Zn	  
peak	  increased	  in	  intensity,	  while	  a	  separate	  Y2K	  PYRIT-­‐Zn-­‐BF4	  peak	  developed	  and	  grew	  rapidly	  
in	  size.	  	  This	  shows	  that	  the	  peptide	  was	  binding	  the	  zinc	  metal	  as	  well	  as	  binding	  one	  of	  the	  
tetrafluoroborate	  counterions.	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Figure	  3.5:	  Mass	  spectra	  (ESI-­‐QToF)	  of	  Y2K(PYRIT)	  during	  titration	  with	  Zn(BF4)2.	  
	   A	  mass	  spectrometry	  study	  was	  also	  completed	  using	  copper	  cations.	  	  The	  Y2K	  PYRIT	  
peptide	  was	  first	  analyzed	  without	  adding	  in	  any	  Cu(II)	  ([M+2H]2+	  =	  753.8126).	  	  Aliquots	  of	  
aqueous	  copper(II)	  nitrate	  were	  then	  added	  to	  achieve	  Cu(II)	  stoichiometries	  of	  0.1,	  0.2,	  0.5,	  
1.0,	  2.0,	  and	  5.0	  relative	  to	  peptide.	  	  As	  shown	  in	  Figure	  3.6	  the	  initial	  sample	  contained	  no	  
peptide	  bound	  to	  copper.	  	  As	  the	  Cu(II)	  was	  titrated	  in,	  the	  Y2K	  PYRIT-­‐Cu	  peak	  ([M+2H]2+	  =	  
784.3383)	  continued	  intensifying	  until	  after	  5.0	  eq	  were	  present,	  at	  which	  point	  there	  was	  no	  
unbound	  Y2K	  PYRIT	  left.	  	  This	  shows	  that	  all	  of	  the	  peptide	  in	  solution	  was	  bound	  to	  copper	  
cations	  and	  suggests	  that	  the	  PYRIT	  functional	  group	  is	  a	  very	  effective	  copper-­‐binding	  moiety.	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Figure	  3.6:	  Mass	  spectra	  (ESI-­‐QToF)	  of	  Y2K(PYRIT)	  during	  titration	  with	  Cu(NO3)2.	  
3.4	  UV-­‐Vis	  Spectrometry	  Studies	  
	   The	  Y2K	  PYRIT	  peptide	  was	  analyzed	  using	  UV-­‐Vis	  spectroscopy	  to	  determine	  which	  
residues	  in	  the	  sequence	  have	  the	  greatest	  affinity	  for	  copper.	  	  Before	  performing	  the	  UV-­‐Vis	  
analysis	  of	  Y2K	  PYRIT,	  absorption	  spectra	  were	  obtained	  for	  copper(II)	  complexes	  of	  the	  simple	  
ligands	  pyridine,	  imidazole,	  and	  acetate	  as	  shown	  in	  Tables	  3.1,	  3.2,	  and	  3.3,	  respectively.	  Here,	  
solutions	  of	  the	  ligands	  were	  transferred	  into	  aqueous	  Cu(NO3)2	  in	  a	  cuvette	  while	  following	  the	  
shift	  in	  the	  absorption	  maximum.	  	  It	  was	  observed	  that	  pyridine	  shifts	  to	  a	  λmax	  of	  
approximately	  648	  nm	  when	  saturated	  with	  Cu(II).	  	  Imidazole	  yields	  an	  absorption	  maximum	  of	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approximately	  592	  nm	  when	  saturated	  with	  Cu(II),	  while	  acetate	  only	  shifts	  to	  approximately	  
761	  nm.	  
Volume	  (uL)	   λmax	  (nm)	   Abs.	   Eq.	  
1	   796	   0.19253	   0.1	  
2	   782	   0.21421	   0.2	  
5	   753	   0.26093	   0.5	  
10	   721	   0.33540	   1.0	  
20	   682	   0.46239	   2.0	  
40	   648	   0.62975	   4.0	  
Table	  3.1:	  Titration	  of	  7	  M	  pyridine	  into	  a	  22.4	  mM	  Cu(NO3)2	  solution	  showing	  a	  shift	  in	  λmax	  to	  
approximately	  648	  nm	  when	  fully	  saturated.	  
Volume	  (uL)	   λmax	  (nm)	   Abs.	   Eq.	  
1	   780	   0.19484	   0.1	  
2	   765	   0.22973	   0.2	  
5	   729	   0.28957	   0.5	  
10	   684	   0.40951	   1.0	  
20	   617	   0.59593	   2.0	  
40	   592	   0.72260	   4.0	  
Table	  3.2:	  Titration	  of	  7	  M	  Imidazole	  into	  a	  22.4	  mM	  Cu(NO3)2	  solution	  showing	  a	  shift	  in	  λmax	  
to	  approximately	  592	  nm	  when	  fully	  saturated.	  
Volume	  (uL)	   λmax	  (nm)	   Abs.	   Eq.	  
2	   799	   0.19252	   0.1	  
4	   792	   0.21423	   0.2	  
10	   780	   0.25195	   0.5	  
20	   773	   0.30112	   1.0	  
40	   765	   0.35362	   2.0	  
80	   761	   0.39811	   4.0	  
Table	  3.3:	  Titration	  of	  3.5	  M	  sodium	  acetate	  into	  a	  23.8	  mM	  Cu(NO3)2	  solution	  showing	  a	  shift	  
in	  λmax	  to	  approximately	  761	  nm	  when	  fully	  saturated.	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A	  0.196	  M	  copper(II)	  nitrate	  solution	  was	  prepared	  and	  titrated	  into	  a	  1.07	  μM	  Y2K	  
PYRIT	  peptide	  solution	  while	  measuring	  absorbance.	  	  The	  peptide	  solution	  concentration	  was	  
obtained	  by	  first	  measuring	  the	  absorbance	  at	  279	  nm,	  1.2827	  AU.	  Using	  Beer’s	  Law	  and	  the	  
extinction	  coefficient	  for	  tyrosine	  at	  280	  nm	  (1200	  AU/mmole/mL),	  the	  concentration	  was	  
predicted	  to	  be	  1.07	  μM.	  This	  means	  that	  4.83	  mg	  of	  Y2K	  PYRIT	  was	  dissolved	  in	  3	  mL	  of	  
deionized	  water.	  As	  shown	  in	  Figure	  3.7	  below,	  initially	  there	  was	  no	  absorbance	  in	  the	  range	  of	  
500	  –	  900	  nm.	  	  After	  the	  addition	  of	  0.5	  eq	  of	  Cu(NO3)2	  there	  was	  an	  initial	  absorbance	  increase	  
around	  643	  nm.	  This	  increase	  was	  maintained	  until	  2.0	  eq	  were	  present,	  and	  at	  3.0	  eq	  of	  Cu(II)	  
an	  increase	  at	  774	  nm	  was	  observed.	  	  Based	  on	  the	  reference	  absorbance	  maxima	  obtained,	  we	  
conclude	  that	  the	  Y2K	  PYRIT	  initially	  binds	  Cu(II)	  at	  the	  PYRIT	  functional	  group.	  	  Pyridine,	  which	  
is	  most	  similar	  to	  the	  PYRIT	  moiety,	  exhibited	  an	  absorbance	  maxima	  of	  approximately	  648	  nm	  
when	  saturated	  with	  Cu(II),	  while	  imidazole	  and	  acetate	  had	  absorbance	  maxima	  of	  592	  and	  
761	  nm,	  respectively.	  	  Since	  643	  nm	  is	  close	  to	  648	  nm,	  the	  initial	  Cu(II)	  binding	  is	  suspected	  to	  
be	  occurring	  at	  the	  PYRIT	  functional	  group.	  	  Once	  3.0	  eq	  of	  the	  Cu(II)	  cation	  is	  added,	  the	  
absorbance	  maximum	  occurs	  around	  774	  nm.	  Thus,	  once	  there	  are	  3.0	  eq	  present,	  binding	  
takes	  place	  at	  the	  glutamic	  acid	  residue.	  The	  peptide	  may	  still	  be	  binding	  metal	  at	  PYRIT	  but	  the	  
absorbance	  maxima	  is	  covered	  up	  by	  the	  larger	  peak	  at	  774	  nm.	  Although	  binding	  does	  occur	  at	  
the	  Glu	  residue,	  it	  is	  preferred	  at	  PYRIT	  at	  lower	  concentrations	  of	  Cu(II),	  suggesting	  that	  the	  
binding	  is	  highly	  favorable.	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Figure	  3.7:	  Electronic	  absorption	  spectra	  of	  Y2K(PYRIT)	  during	  titration	  with	  Cu(NO3)2.	  λmax	  =	  
643	  nm	  at	  0.5	  eq	  Cu	  (orange);	  1.0	  eq	  (grey),	  and	  2.0	  eq	  (yellow);	  λmax	  =	  774	  nm	  at	  3.0	  eq	  (dark	  
blue)	  and	  4.0	  eq	  (green).	  
3.5	  Circular	  Dichroism	  Studies	  
	   Circular	  dichroism	  was	  utilized	  to	  study	  the	  secondary	  structure	  of	  Y2K	  PYRIT.	  	  The	  
peptide	  was	  first	  analyzed	  without	  adding	  any	  metal,	  and	  then	  approximately	  4	  eq	  of	  Cu(NO3)2	  
was	  added	  and	  another	  spectrum	  was	  acquired.	  As	  shown	  in	  Figure	  3.8,	  alpha-­‐helical	  CD	  
spectra	  tend	  to	  show	  two	  minima	  between	  200	  and	  230	  nm	  while	  β-­‐sheet	  shows	  one	  minimum	  
in	  that	  region.	  Random	  coils	  show	  a	  minimum	  at	  approximately	  195	  nm.19	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Figure	  3.8:	  Far	  UV	  CD	  spectra	  displaying	  secondary	  structure	  characteristics.	  α-­‐helix,	  solid	  
curve;	  antiparallel	  β-­‐sheet,	  long	  dashes;	  type	  I	  β-­‐turn,	  dots;	  and	  random	  coil,	  short	  dashes.19	  
Based	  on	  the	  spectra	  obtained,	  a	  random	  coil	  orientation	  is	  suspected.	  This	  is	  not	  
surprising;	  peptide	  sequences	  of	  fewer	  than	  20	  residues,	  like	  that	  found	  in	  the	  Y2K	  PYRIT	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molecule,	  are	  typically	  unstructured.20	  Furthermore,	  because	  the	  CD	  study	  was	  performed	  in	  
pH	  7.4	  phosphate	  buffer	  and	  not	  in	  a	  nonpolar	  solvent,	  hydrogen-­‐bonds	  that	  might	  stabilize	  a	  
helix	  are	  weakened.	  This	  solvent	  system	  was	  chosen	  to	  simulate	  physiological	  conditions,	  
however	  the	  Rocker	  peptide	  from	  which	  Y2K	  PYRIT	  is	  based	  was	  designed	  to	  incorporate	  into	  
cellular	  membranes.	  	  Therefore	  the	  CD	  study	  needs	  to	  be	  repeated	  using	  propanol,	  octanol,	  
and/or	  liposomes	  to	  determine	  if	  the	  suspected	  alpha	  helical	  secondary	  structure	  is	  observed	  in	  
a	  more	  nonpolar	  environment.	  
	  
Figure	  3.9:	  CD	  spectra	  of	  Y2K(PYRIT)	  	  and	  Y2K(PYRIT)-­‐Cu	  showing	  random	  coil-­‐like	  secondary	  
structure	  in	  pH	  7.4	  phosphate	  buffer	  solution.	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Conclusions	  
	   Lys(PYRIT)	  has	  been	  shown	  to	  be	  an	  effective	  metal	  chelator	  that	  can	  be	  incorporated	  
into	  peptides	  through	  two	  routes:	  Solution-­‐phase	  synthesis	  of	  Fmoc-­‐Lys(PYRIT)-­‐OH	  followed	  by	  
standard	  solid	  phase	  peptide	  synthesis,	  or	  click	  chemistry	  upon	  a	  resin-­‐bound	  Fmoc-­‐Lys(N3).	  
This	  novel	  amino	  acid	  has	  been	  shown	  to	  bind	  Cu2+	  and	  Zn2+	  efficiently	  via	  UV-­‐Vis,	  NMR,	  and	  
ESI-­‐MS.	  Future	  work	  will	  be	  focused	  on	  running	  azide	  transfer	  and	  click	  reactions	  upon	  full	  
peptides	  with	  native	  lysine	  residues	  already	  present.	  If	  successful,	  the	  PYRIT	  side-­‐chain	  could	  
find	  broad	  use	  as	  a	  means	  to	  add	  metal-­‐binding	  functionality	  at	  sites	  where	  it	  otherwise	  
wouldn’t	  be.	  Circular	  dichroism	  studies	  will	  also	  be	  repeated	  using	  propanol,	  octanol,	  or	  
liposomes	  to	  simulate	  a	  nonpolar	  cellular	  membrane.	  	  It	  is	  expected	  that	  Y2K	  PYRIT	  should	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EXPERIMENTAL	  
Synthesis	  of	  Fmoc-­‐Lys(N3)-­‐OH:15,16	  Commercially	  available	  Fmoc-­‐Lys-­‐OH	  (1.14	  g,	  3.10	  mmol)	  
was	  suspended	  in	  40	  mL	  of	  CH2Cl2	  /	  20	  mL	  H2O	  /	  10	  mL	  EtOH,	  and	  1.95	  g	  (9.30	  mmol)	  of	  azido-­‐
transfer	  reagent	  was	  added.	  	  CuSO45H2O	  (8.0	  mg,	  0.05	  mmol)	  was	  introduced,	  and	  the	  pH	  was	  
increased	  from	  2	  to	  approximately	  8-­‐9	  with	  aq.	  K2CO3.	  	  The	  resultant	  biphasic	  suspension	  was	  
light	  blue	  in	  color	  and	  slightly	  opaque.	  The	  reaction	  was	  allowed	  to	  run	  for	  20	  hours	  before	  
acidifying	  using	  10%	  aq.	  HCl	  to	  pH	  of	  6.	  The	  mixture	  was	  transferred	  to	  a	  separatory	  funnel	  and	  
diluted	  with	  75	  mL	  CH2Cl2.	  The	  organic	  layer	  was	  washed	  with	  brine	  and	  dried	  over	  Na2SO4,	  
before	  being	  filtered.	  	  The	  faintly	  blue	  filtrate	  was	  then	  rotovapped	  and	  a	  partially	  viscous	  blue	  
liquid	  was	  obtained	  and	  dried	  under	  vacuum	  for	  40	  minutes.	  The	  crude	  yield	  was	  1.26	  g.	  This	  
material	  was	  dissolved	  in	  100	  mL	  of	  CH2Cl2	  and	  washed	  with	  10%	  HCl	  then	  brine	  before	  being	  
dried	  over	  Na2SO4.	  After	  filtration	  and	  evaporation,	  the	  faintly	  gold	  oil	  was	  dried	  under	  vacuum	  
to	  afford	  1.20	  g	  (3.08	  mmol,	  98%)	  of	  Fmoc-­‐Lys(N3)-­‐OH.	  	  
Synthesis	  of	  Fmoc-­‐Lys(PYRIT)-­‐OH:17	  Freshly	  prepared	  Fmoc-­‐Lys(N3)-­‐OH	  (564	  mg,	  1.43	  mmol)	  
was	  dissolved	  in	  35	  mL	  of	  dioxane	  and	  15	  mL	  of	  deionized	  water.	  	  Approximately	  1.5	  eq	  of	  2-­‐
ethynylpyridine	  (221	  mg)	  was	  added	  to	  the	  solution	  along	  with	  CuI	  (14.8	  mg)	  and	  sodium	  
ascorbate	  (18.1	  mg).	  	  The	  clear,	  dark	  yellow	  solution	  was	  allowed	  to	  stir	  at	  room	  temperature	  
for	  18	  h,	  during	  which	  time	  the	  color	  became	  dark	  purple.	  The	  solvents	  were	  removed	  by	  rotary	  
evaporation	  and	  50	  mL	  of	  CH2Cl2	  was	  added	  to	  the	  dried	  product.	  The	  solution	  was	  washed	  
three	  times	  in	  a	  separatory	  funnel	  with	  10	  mL	  of	  10%	  HCl.	  	  Copper	  precipitated	  out	  of	  solution	  
during	  the	  acid	  wash.	  	  The	  organic	  layer	  was	  isolated	  and	  dried	  over	  Na2SO4.	  The	  liquid	  was	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then	  filtered	  and	  the	  filtrate	  evaporated	  under	  reduced	  pressure.	  Approximately	  600	  mg	  of	  a	  
solid,	  gel-­‐like	  brown	  product	  was	  obtained	  and	  further	  purified	  via	  reversed-­‐phase	  HPLC.	  HPLC	  
was	  performed	  using	  a	  Vydac	  Protein	  and	  Peptide	  C18	  prep	  scale	  column	  (22	  x	  250	  mm,	  20	  μm)	  
at	  a	  flow	  rate	  of	  10.00	  mL/min	  and	  a	  linear	  gradient	  from	  25%	  CH2Cl2	  /	  75%	  H2O	  to	  75%	  CH2Cl2	  /	  
25%	  H2O	  over	  30	  minutes	  while	  detecting	  at	  300	  nm.	  The	  Fmoc-­‐Lys(PYRIT)-­‐OH	  eluted	  at	  16.5	  
minutes	  and	  was	  then	  lyophilized.	  	  After	  lyophilization,	  55	  mg	  of	  product	  was	  obtained	  
providing	  a	  2.5%	  yield	  after	  purification.	  	  The	  identity	  of	  the	  product	  was	  confirmed	  using	  ESI-­‐
QToF-­‐MS	  (m/z	  calcd	  for	  [M+H]+	  498.2136;	  found	  498.0922).	  
An	  on-­‐resin	  azide-­‐alkyne	  “click”	  reaction.	  Synthesis	  of	  YYKEIAHALK(PYRIT)SA-­‐CONH2:	  The	  
reaction	  vessel	  of	  an	  automated	  peptide	  synthesizer	  programmed	  for	  standard	  Fmoc	  solid-­‐
phase	  protocols	  was	  charged	  with	  339	  mg	  of	  Rink	  Amide	  MBHA	  resin	  (loading	  0.59	  mmol/g,	  
0.20	  mmol)	  and	  12.0	  mg	  of	  CuI.	  Vials	  containing	  the	  appropriate	  Fmoc-­‐protected	  amino	  acids	  
and	  HBTU	  (0.60	  mmol	  of	  each)	  were	  set	  into	  the	  carousel.	  Duplicate	  vials	  were	  prepared	  to	  
allow	  for	  double	  coupling	  of	  residues	  Y1,	  Y2,	  L9,	  K(N3)10,	  and	  A12.	  The	  PYRIT-­‐functionalized	  
side-­‐chain	  of	  residue	  10	  was	  constructed	  in	  situ	  by	  first	  appending	  Fmoc-­‐Lys(N3)-­‐OH	  to	  the	  
growing	  strand	  in	  the	  usual	  manner.	  Upon	  advancing	  to	  the	  next	  vial,	  the	  synthesizer	  dissolved	  
the	  contents	  (2-­‐ethynylpyridine	  (62	  mg)	  and	  sodium	  ascorbate	  (20	  mg))	  in	  DMF,	  and	  
transferred	  the	  alkyne	  solution	  to	  the	  reaction	  vessel.	  After	  90	  minutes,	  with	  periodic	  agitation	  
of	  the	  resin	  and	  Cu(I)	  salt	  provided	  only	  by	  automated	  nitrogen	  bubbling,	  the	  synthesizer	  
deprotected	  the	  newly-­‐formed	  Fmoc-­‐Lys(PYRIT)	  residue	  and	  completed	  the	  remainder	  of	  the	  
synthesis.	  The	  resin	  was	  removed	  from	  the	  reaction	  vessel,	  rinsed	  with	  glacial	  CH3COOH,	  
CH2Cl2,	  and	  finally	  CH3OH,	  and	  dried	  under	  high	  vacuum	  for	  2	  h.	  The	  peptide	  was	  cleaved	  from	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the	  resin	  by	  treatment	  with	  a	  mixture	  of	  TFA/TIS/anisole/water	  for	  1	  h,	  and	  was	  precipitated	  by	  
addition	  of	  ice-­‐cold	  diethyl	  ether.	  The	  crude	  material	  so	  obtained	  (175	  mg)	  was	  purified	  by	  
preparative-­‐scale	  RP-­‐HPLC	  on	  a	  C18	  column	  (22	  x	  250	  mm,	  20	  μm),	  using	  a	  linear	  gradient	  of	  
100%	  water	  to	  100%	  CH3CN	  at	  a	  flow	  rate	  of	  10	  mL/min	  over	  30	  minutes.	  Four	  peaks	  that	  
absorbed	  at	  300	  nm	  were	  observed,	  at	  retention	  times	  of	  13:30,	  17:55,	  18:45,	  and	  21:00.	  The	  
second	  of	  these	  was	  found	  to	  be	  an	  11-­‐mer	  lacking	  Y,	  but	  the	  third	  peak	  proved	  to	  be	  the	  
desired	  12-­‐mer	  by	  ESI-­‐QToF	  mass	  spectrometry	  (m/z	  calcd	  for	  [M	  +	  H]+	  1521.7961,	  found	  
1521.7620;	  calcd	  for	  [M	  +	  2H]2+	  761.4017,	  found	  761.3987).	  The	  eluate	  was	  lyophilized	  to	  a	  
white	  powder.	  	  
	   Studies	  of	  metal	  binding	  by	  proton	  NMR	  were	  completed	  using	  a	  Bruker	  400	  MHz	  
instrument	  over	  256	  scans	  each.	  Y2K	  PYRIT	  (2.3	  mg)	  was	  dissolved	  in	  1.00	  mL	  D2O	  and	  a	  
spectrum	  was	  acquired	  with	  no	  metal	  added.	  Zinc(II)	  tetrafluoroborate	  (370	  mg)	  was	  dissolved	  
in	  10.00	  mL	  of	  D2O	  and	  then	  titrated	  into	  the	  NMR	  tube	  containing	  the	  peptide	  sample.	  	  After	  
each	  addition	  of	  Zn(II),	  a	  spectrum	  was	  acquired	  and	  proton	  shifts	  were	  observed.	  It	  was	  found	  
that	  the	  proton	  signals	  corresponding	  to	  the	  PYRIT	  protons	  shifted	  downfield	  with	  the	  addition	  
of	  Zn(II).	  
	   Mass	  spectra	  were	  acquired	  on	  a	  Micromass	  Q-­‐ToF	  Micro	  mass	  spectrometer	  with	  
electrospray	  ionization	  source.	  The	  samples	  were	  dissolved	  in	  1:1	  acetonitrile/water	  solutions	  
and	  spectra	  were	  obtained	  over	  a	  100	  –	  3200	  m/z	  range.	  	  Parameters	  used	  during	  ESI-­‐MS	  
analysis	  are	  listed	  in	  Table	  4.1	  below.	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Ion	  Mode	   ES	  +	  Flow	  Rate	   10	  μL/min	  Source	  Temperature	   80°C	  Desolvation	  Temperature	   120°C	  Capillary	  Voltage	   2500	  V	  Sample	  Cone	   30	  V	  Extraction	  Cone	   2.0	  V	  Cone	   20	  L/hr	  Desolvation	   500	  L/hr	  
	  
Table	  4.1:	  Mass	  spectrometry	  parameters.	  
	   Absorption	  spectra	  were	  obtained	  using	  an	  Agilent	  Cary	  8454	  UV-­‐Vis.	  	  The	  spectra	  were	  
acquired	  from	  190	  nm	  to	  850	  nm	  using	  a	  3.0	  mL	  quartz	  cuvette	  with	  path	  length	  1	  cm.0	  
CD	  studies	  were	  performed	  using	  pH	  7.4	  phosphate	  buffer	  and	  1.0	  mm	  quartz	  cuvettes.	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